Covered recipient · General Payments record
GABRIEL T TATARIAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$221,448.80
- Reported across 269 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,400.00 | 4 |
| Food and Beverage | $1,167.04 | 33 |
| Travel and Lodging | $663.90 | 1 |
| Education | $15.50 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| TG THERAPEUTICS, INC. | $3,706.30 | 10 |
| Biogen, Inc. | $928.98 | 8 |
| Lilly USA, LLC | $71.04 | 3 |
| ABBVIE INC. | $70.36 | 3 |
| UCB, Inc. | $69.81 | 2 |
| Abbott Laboratories | $64.61 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $56.50 | 2 |
| EISAI INC. | $48.19 | 2 |
| EMD Serono, Inc. | $44.29 | 2 |
| Merz Pharmaceuticals, LLC | $36.04 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.85 | 1 |
| CSL Behring | $31.93 | 1 |
| Lundbeck LLC | $24.70 | 1 |
| PFIZER INC. | $24.70 | 1 |
| ARGENX US, INC. | $21.19 | 1 |
| REVANCE THERAPEUTICS, INC. | $14.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (40)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $64.61 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124876836 | CMS |
| ABBVIE INC. | $29.89 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106203820 | CMS |
| ABBVIE INC. | $18.59 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106203822 | CMS |
| ABBVIE INC. | $21.88 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106203824 | CMS |
| ARGENX US, INC. | $21.19 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142105295 | CMS |
| Biogen, Inc. | $343.00 | 04/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104809215 | CMS |
| Biogen, Inc. | $343.00 | 04/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104812571 | CMS |
| Biogen, Inc. | $171.00 | 04/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104875434 | CMS |
| Biogen, Inc. | $17.13 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104860616 | CMS |
| Biogen, Inc. | $10.00 | 08/01/2024 | Education | Undisputed | 01/23/2026 | 1104849600 | CMS |
| Biogen, Inc. | $25.00 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104816987 | CMS |
| Biogen, Inc. | $5.50 | 08/13/2024 | Education | Undisputed | 01/23/2026 | 1104868936 | CMS |
| Biogen, Inc. | $14.35 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104868562 | CMS |
| CSL Behring | $31.93 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134612791 | CMS |
| Eisai Inc. | $22.13 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110746062 | CMS |
| Eisai Inc. | $26.06 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110746060 | CMS |
| EMD Serono, Inc. | $22.00 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120238186 | CMS |
| EMD Serono, Inc. | $22.29 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120271542 | CMS |
| Lilly USA, LLC | $25.62 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134982760 | CMS |
| Lilly USA, LLC | $28.15 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134977038 | CMS |
| Lilly USA, LLC | $17.27 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134983802 | CMS |
| Lundbeck LLC | $24.70 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145974450 | CMS |
| Merz Pharmaceuticals, LLC | $36.04 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137949204 | CMS |
| Novartis Pharmaceuticals Corporation | $26.39 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087433672 | CMS |
| Novartis Pharmaceuticals Corporation | $30.11 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087433674 | CMS |
| PFIZER INC. | $24.70 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132127597 | CMS |
| REVANCE THERAPEUTICS, INC. | $14.95 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930461 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.85 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137686294 | CMS |
| TG Therapeutics, Inc. | $24.73 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136883764 | CMS |
| TG Therapeutics, Inc. | $663.90 | 05/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1136883798 | CMS |
| TG Therapeutics, Inc. | $2,543.00 | 05/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136883814 | CMS |
| TG Therapeutics, Inc. | $48.98 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136883912 | CMS |
| TG Therapeutics, Inc. | $102.04 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136883916 | CMS |
| TG Therapeutics, Inc. | $114.26 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136883806 | CMS |
| TG Therapeutics, Inc. | $68.75 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136883914 | CMS |
| TG Therapeutics, Inc. | $100.59 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136883820 | CMS |
| TG Therapeutics, Inc. | $24.96 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136883784 | CMS |
| TG Therapeutics, Inc. | $15.09 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136883834 | CMS |
| UCB, Inc. | $23.78 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143459922 | CMS |
| UCB, Inc. | $46.03 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143459927 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.